UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000046065
Receipt number R000052509
Scientific Title An preliminary study of a mindfulness-based intervention using VR for anxiety disorders
Date of disclosure of the study information 2021/11/13
Last modified on 2023/06/10 15:17:39

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

An preliminary study of a mindfulness-based intervention using VR for anxiety disorders

Acronym

An preliminary study of a mindfulness-based intervention using VR for anxiety disorders

Scientific Title

An preliminary study of a mindfulness-based intervention using VR for anxiety disorders

Scientific Title:Acronym

An preliminary study of a mindfulness-based intervention using VR for anxiety disorders

Region

Japan


Condition

Condition

anxiety disorders

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To preliminarily investigate the feasibility (enrollment rate, dropout rate, retention rate) and effectiveness of a mindfulness-based program using VR for anxiety disorders.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Phase II


Assessment

Primary outcomes

1) enrollment rate, 2) dropout rate, 3)retention rate, 4) mean and standardized deviation of the clinical parameters (STAI) at baseline and 2month

Key secondary outcomes

mean and standardized deviation of the following clinical parameters at baseline and 2month: PAS, LSAS-J, Experiences Questionaire, RSES, FFMQ, CD-RISC, SCS, QIDS, PSS, HPQ, SWLS, FS, EQ-5D.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Behavior,custom

Interventions/Control_1

mindfulness-based program (mindfulness-based cognitive therapy) using VR

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >=

Gender

Male and Female

Key inclusion criteria

/Diagnosed as panic disorder, agoraphobia, or social anxiety disorder, based on DSM-4
/ No remission after 4 week's pharmacotherapy
/Ability to consent in writing

Key exclusion criteria

/Substance related disorders
/Severe suicidal ideation or self-harm behaviour
/Severe general medical conditions
/Unsuitable for participation in the research in the opinion of the principal investigator

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Mitsuhiro
Middle name
Last name Sado

Organization

Keio University School of Medicine

Division name

Department of Neuropsychiatry

Zip code

160-0016

Address

35 Shinanomachi, Shinjuku-ku, Tokyo

TEL

+81-(0)3-3353-1211

Email

mitsusado@keio.jp


Public contact

Name of contact person

1st name Akira
Middle name
Last name Ninomiya

Organization

Keio University School of Medicine

Division name

Department of Neuropsychiatry

Zip code

160-0016

Address

35 Shinanomachi, Shinjuku-ku, Tokyo

TEL

+81-(0)3-3353-1211

Homepage URL


Email

akira-ninomiya@keio.jp


Sponsor or person

Institute

Keio University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

The Ministry of Education,Culuture,Sports,Science and Technology

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Keio University School of Medicine

Address

35 Shinanomachi, Shinjuku-ku, Tokyo

Tel

+81-(0)3-3353-1211

Email

med-rinri-jimu@adst.keio.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 11 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

4

Results


Results date posted


Results Delayed

Delay expected

Results Delay Reason

Due to the delay in analysis.

Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2021 Year 10 Month 01 Day

Date of IRB

2021 Year 10 Month 29 Day

Anticipated trial start date

2021 Year 11 Month 13 Day

Last follow-up date

2022 Year 02 Month 15 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 11 Month 13 Day

Last modified on

2023 Year 06 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052509